CCN2 and syringocystadenoma papilliferum: Recent studies have stressed that miR-26a-5p can inhibit TLR signaling by suppressing CTGF expression and reducing pro-inflammatory factor expression in alveolar macrophages in mice, which has meant CTGF can serve as a potential target for predicting and treating SCAP (24).